Cancel
Known information
- Holds a Doctorate in Mechanical Engineering from the University of Florida
- Is a Fuqua Scholar with an MBA from Duke University's Fuqua School of Business
- Co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes for non-invasive imaging and destruction of solid tumors
- Previously served as the CEO/President of Convergent Life Sciences, where he led the FDA clearance of a MRI-US fusion product for targeted laser ablation of soft tissue cancer within 18 months of company formation
- Was the VP of Strategy and Operations at Eigen, where he led the development and successful commercialization of two class II medical devices in the prostate biopsy space
- Serves as a board member at Navaux and an advisor to Fanisko, Triocula, and UnityDx
- Is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space
About Promaxo
Promaxo specializes in an innovative modular MRI system designed for use in physicians' offices, featuring AI-based imaging for prostate interventions and a design that enhances patient comfort.
Report inaccurate information
